Novel Therapeutic Approaches for Treatment-Resistant Depression
A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Neuropsychiatry".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 72
Special Issue Editor
Special Issue Information
Dear Colleagues,
Treatment-resistant/hard-to-treat depression poses a significant clinical challenge, affecting a substantial subset of individuals who fail to respond to conventional pharmacological and psychotherapeutic approaches. Despite the growing burden of depression on patients and healthcare systems, current interventions remain limited in efficacy and accessibility.
This Special Issue aims to highlight innovative and emerging therapeutic strategies, including but not limited to neuromodulation techniques (e.g., TMS, ECT, MST, tDCS, PBM, etc.), psychedelic-assisted therapy, digital therapeutics, precision medicine approaches, and novel pharmacological agents (ketamine, esketamine, etc.). We also welcome research exploring biomarkers, mechanisms of action, and personalized treatment frameworks through qualitative methodology.
We invite original research articles, clinical trials, reviews, and translational studies that advance our understanding or clinical management of hard-to-treat depression. Submissions that incorporate multidisciplinary approaches or examine real-world applications and long-term outcomes are especially encouraged.
Dr. Yuliya O. Knyahnytska
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- treatment resistant depression
- hard-to-treat mood disorders
- innovative interventions
- therapeutic brain stimulation interventions
- neuromodulation interventions
- novel psychotropics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
